Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial. - Brose, Marcia S.; Nutting, Christopher M.; Jarzab, Barbara; Elisei, Rossella; Siena, Salvatore; Bastholt, Lars; de la Fouchardiere, Christelle; Pacini, Furio; Paschke, Ralf; Young Kee Shong; Sherman, Steven I.; Smit, Johannes W. A.; et al. (Lancet, 2014)